Contribution of mercaptopurine dose intensification to improved outcome in patients with lower-risk ALL.
Abromowitch
M
M
Fairclough
D
D
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D006801:Humans; D015122:Mercaptopurine / Q000008:administration & dosage*; D008727:Methotrexate / Q000008:administration & dosage; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D012307:Risk Factors
D015122:Mercaptopurine; D008727:Methotrexate